- Home
- PYXS vs ATPC Comparison
PYXS vs ATPC Comparison
Compare PYXS & ATPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PYXS
- ATPC
- Stock Information
- Founded
- PYXS 2018
- ATPC 2016
- Country
- PYXS United States
- ATPC Malaysia
- Employees
- PYXS N/A
- ATPC N/A
- Industry
- PYXS Biotechnology: Pharmaceutical Preparations
- ATPC Medical/Nursing Services
- Sector
- PYXS Health Care
- ATPC Health Care
- Exchange
- PYXS Nasdaq
- ATPC Nasdaq
- Market Cap
- PYXS 75.0M
- ATPC 68.0M
- IPO Year
- PYXS 2021
- ATPC N/A
- Fundamental
- Price
- PYXS $1.34
- ATPC $1.32
- Analyst Decision
- PYXS Buy
- ATPC
- Analyst Count
- PYXS 4
- ATPC 0
- Target Price
- PYXS $8.67
- ATPC N/A
- AVG Volume (30 Days)
- PYXS 443.9K
- ATPC 50.3K
- Earning Date
- PYXS 08-14-2025
- ATPC 08-13-2025
- Dividend Yield
- PYXS N/A
- ATPC N/A
- EPS Growth
- PYXS N/A
- ATPC N/A
- EPS
- PYXS N/A
- ATPC N/A
- Revenue
- PYXS $2,820,000.00
- ATPC $1,445,601.00
- Revenue This Year
- PYXS N/A
- ATPC N/A
- Revenue Next Year
- PYXS N/A
- ATPC N/A
- P/E Ratio
- PYXS N/A
- ATPC N/A
- Revenue Growth
- PYXS N/A
- ATPC 4.90
- 52 Week Low
- PYXS $0.83
- ATPC $0.90
- 52 Week High
- PYXS $5.39
- ATPC $3.49
- Technical
- Relative Strength Index (RSI)
- PYXS 65.01
- ATPC 48.21
- Support Level
- PYXS $1.14
- ATPC $1.24
- Resistance Level
- PYXS $1.38
- ATPC $1.36
- Average True Range (ATR)
- PYXS 0.09
- ATPC 0.08
- MACD
- PYXS 0.03
- ATPC 0.00
- Stochastic Oscillator
- PYXS 80.43
- ATPC 57.14
About PYXS Pyxis Oncology Inc.
Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. It develops the product candidates with the objective to directly kill tumor cells, and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion.
About ATPC Agape ATP Corporation
Agape ATP Corp through its subsidiaries is engaged in providing health and wellness products and health solution advisory services. The principal activities of the company is to supply high-quality health and wellness products, including supplements to assist in cell metabolism, detoxification, blood circulation, anti-aging and products designed to improve the overall health system of the human body and various wellness programs. Its segments include: Skin care, health and wellness segment includes the provision of health and wellness products and health solution advisory services; and Green energy segment includes providing renewable energy products, technical solutions, installations and maintenance services. It derives maximum revenue from Skin care, health and wellness segment.